LeserbriefKommentar
Renin-Angiotensin System Modulation in Adults With COVID-19
JAMA · 2023
DOI: 10.1001/jama.2023.10783 ↗Kurz gefasst
Leserbrief in der Zeitschrift JAMA, 2023. Verfasst von Robson Augusto Souza Dos Santos und 2 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Fisiologia e Biofísica, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Drug Treatment, Renin-Angiotensin System. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
COVID-19COVID-19 Drug TreatmentRenin-Angiotensin SystemAdultHumansAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsPeptidyl-Dipeptidase A
Substanzen
Angiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsPeptidyl-Dipeptidase A
Autor:innen und Institutionen
- Departamento de Fisiologia e Biofísica, Federal University of Minas Gerais, Belo Horizonte, MG, Brazil.
- Department of Intensive Care, Hôpital Universitaire de Bruxelles, Brussels, Belgium.
Zitieren
APA
Dos Santos, R. A. S., Taccone, F. S., & Annoni, F. (2023). Renin-Angiotensin System Modulation in Adults With COVID-19. JAMA. https://doi.org/10.1001/jama.2023.10783
Vancouver
Dos Santos RAS, Taccone FS, Annoni F. Renin-Angiotensin System Modulation in Adults With COVID-19. JAMA. 2023. doi:10.1001/jama.2023.10783
BibTeX
@article{DosSantos2023,
author = {Dos Santos, Robson Augusto Souza and Taccone, Fabio Silvio and Annoni, Filippo},
title = {Renin-Angiotensin System Modulation in Adults With COVID-19},
journal = {JAMA},
year = {2023},
doi = {10.1001/jama.2023.10783}
}
EUVIMED